"Welcome to SSJ Finance"

Profit & Loss Accounts

Quarterly Results

Divis Laboratories Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs	Chairman : Ramesh B V Nimmagadda
Home : Indian Private	Book Value: 629.4942217
BSE Code : 532488	Market Cap: 190744.48
NSE Code : DIVISLAB	P / E : 71.64

Change Company :

Quarters:

(Rs in Cr.)

Quarterly Results

Particulars	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Type	4Qtr	3Qtr	2Qtr	1Qtr
Net Sales	2793.00	2578.00	2660.00	2357.00
Other Income	154.00	87.00	146.00	119.00
Total Income	2947.00	2665.00	2806.00	2476.00
Total Expenditure	1850.00	1745.00	1765.00	1614.00
Operating Profit	1097.00	920.00	1041.00	862.00
Interest	6.00	6.00	8.00	3.00
Gross Profit	1091.00	914.00	1033.00	859.00
Depreciation	120.00	116.00	113.00	112.00
Tax	250.00	208.00	220.00	191.00
Deferred Tax	-35.00	-8.00	4.00	-1.00
Reported Profit After Tax	756.00	598.00	696.00	557.00

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822

SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527

Content powered by Capital Market Charts are powered by TradingView